Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-693
Closed -$50K 385
2023
Q4
$50K Sell
693
-546
-44% -$38K ﹤0.01% 348
2023
Q3
$86K Sell
1,239
-845
-41% -$63.9K 0.01% 295
2023
Q2
$169K Buy
2,084
+1,272
+157% +$104K 0.01% 268
2023
Q1
$66K Sell
812
-1,262
-61% -$102K ﹤0.01% 333
2022
Q4
$155K Sell
2,074
-1,996
-49% -$142K 0.01% 222
2022
Q3
$263K Sell
4,070
-47,986
-92% -$3.32M 0.02% 189
2022
Q2
$3.61M Buy
52,056
+50,954
+4,624% +$3.78M 0.23% 80
2022
Q1
$85K Buy
1,102
+223
+25% +$16K ﹤0.01% 325
2021
Q4
$67K Hold
879
﹤0.01% 315
2021
Q3
$65K Hold
879
﹤0.01% 325
2021
Q2
$59K Hold
879
﹤0.01% 326
2021
Q1
$65K Hold
879
﹤0.01% 301
2020
Q4
$64K Hold
879
﹤0.01% 290
2020
Q3
$58K Buy
+879
New +$55.6K ﹤0.01% 276
2014
Q4
Sell
-1,387,708
Closed -$33.8M 142
2014
Q3
$33.8M Buy
1,387,708
+337,528
+32% +$8.52M 0.95% 38
2014
Q2
$26.6M Buy
1,050,180
+286,838
+38% +$6.7M 1.18% 32
2014
Q1
$16.4M Buy
763,342
+333,618
+78% +$7.2M 0.82% 49
2013
Q4
$9.6M Buy
+429,724
New +$9.48M 0.49% 53

Other funds holding HOLX

TOBAM's HOLX Position: Q1 2024 in Review

TOBAM sold out of Hologic (HOLX) in Q1 2024, closing a stake of 693 shares — an estimated $50K sold.

TOBAM first reported a position in HOLX in Q4 2013 and held it in 18 quarters. The position peaked at $33.8M in Q3 2014. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • TOBAM reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • TOBAM sold 693 Hologic shares in Q1 2024, an estimated $50K.
  • TOBAM first reported a position in Hologic in Q4 2013 and held it in 18 quarters.
  • TOBAM's Hologic position peaked at $33.8M in Q3 2014.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on TOBAM's 13F filing for Q1 2024, filed 2 May 2024.